HY Q1 2026 Earnings Narrowing Losses as Cost Initiatives Gain Traction ASR Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Weigh WTS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment FMBH Q1 2026 Earnings EPS Beats Estimates by 531 as Shares Rise